Ann: Increased Scheme Consideration from Pfizer, page-113

Pfizer is trying to scare us off. I am laughing at this "14c if it is not validated". They have forgotten about (or conveniently not to mention) so many things. To name a few here:
1) Quarterly revenue report is coming. If it is up another 44% and is over $250k, many people will hold firm
2) I am sure that Pfizer has been dealing with us for more than 3 months. It will be unimaginable that it has not try validating our app one way or another. So the chance is quite low for the validation to fail
3) If the validation succeeds, that means FDA, so no one will sell
4) Most important. The time is on our side. Pfizer needs to buy us and then prepare/lodge for FDA and get approved BEFORE the winter season in USA. The time line is very tight. they need to close the deal asap. When it comes to winter, they need a tool which can differentiate flu from COVID. Our tool will be the perfect fit.

So guys, please hold tight. The game is not over, it is finally on. BTW, a big NO from us.